Holen Sie sich die Stockscreener-App
3.36
3.07%
0.10
Handel nachbörslich:
3.29
-0.07
-2.08%
Finanzdaten der Taysha Gene Therapies Inc-Aktie (TSHA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
13.73%
1.986
|
2.302 | 2.022 | 1.788 | 1.112 |
Operating Expenses
|
21.14%
28.74
|
23.72 | 21.95 | 27.69 | 22.41 |
| Benefits Costs and Expenses |
21.14%
28.87
|
23.83 | 20.81 | - | - |
| Costs And Expenses |
21.14%
28.87
|
23.83 | 20.81 | 27.69 | 22.41 |
| Operating Income/Loss |
24.89%
-26.75
|
-21.42 | -19.93 | -25.90 | -21.30 |
| Nonoperating Income/Loss |
19.44%
-0.129
|
-0.108 | 1.147 | 0.374 | 0.371 |
| Income/Loss From Continuing Operations Before Tax |
24.86%
-26.88
|
-21.53 | -18.79 | 1.788 | 1.112 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
24.86%
-26.88
|
-21.53 | -18.79 | -25.52 | -20.93 |
|
Net Income/Loss
|
24.86%
-26.88
|
-21.53 | -18.79 | -25.52 | -20.93 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.65%
297.99
|
269.31 | 6.0824 | 267.82 | 232.82 |
| Diluted Average Shares |
10.65%
297.99
|
269.31 | 6.0824 | 267.82 | 232.82 |
| Basic Earnings Per Share |
12.50%
-0.09
|
-0.08 | -0.07 | -0.10 | -0.09 |
| Diluted Earnings Per Share |
12.50%
-0.09
|
-0.08 | -0.07 | -0.10 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):